Biora Therapeutics, Inc.

Ownership Transactions Reported by 19 Insiders

Symbol
BIOR on Nasdaq
Industry
Pharmaceutical Preparations
Location
4330 La Jolla Village Drive, Suite 200, San Diego, California

There are no Buy or Sell transactions made by insiders since 7/6/2023

Biora Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Athyrium Opportunities Fund (A) LP 10%+ Owner $134 M Jun 14, 2021
Athyrium Capital Management, LP 10%+ Owner $134 M Jun 14, 2021
Athyrium Opportunities III Co-Invest 1 LP Director, 10%+ Owner $46.8 M Dec 18, 2023
Harry Stylli Chairman & CEO, Director, 10%+ Owner $46.5 M Aug 15, 2021
Aditya P. Mohanty Chief Executive Officer $2.26 M Feb 15, 2024
Damon Silvestry President and General Manager, Avero $915 K Nov 15, 2021
Eric dEsparbes Chief Financial Officer $875 K Feb 15, 2024
Clarke Neumann Senior Vice President, General Counsel and Secretary $823 K Feb 15, 2024
Surbhi Sarna Director $467 K Jan 3, 2023
Matthew T. Cooper General Manager, Diagnostics $421 K Nov 15, 2021
Sami Shihabi Chief Commercial Officer $396 K May 15, 2021
Troy Seelye Chief Information Officer $188 K Aug 6, 2021
John T. Bigalke Director $149 K Jun 14, 2021
Samuel R. Nussbaum Director $149 K Jun 14, 2021
Hutan Hashemi Chief Compliance Officer $89.5 K Feb 15, 2022
Jill Ann Howe Director $61 K Jun 5, 2024
Jeffrey D. Alter Director $59.8 K Jun 5, 2024
Lynne Powell Director $57.3 K Jun 5, 2024
Brian L. Kotzin Director $57.3 K Jun 5, 2024

Recent Insider Transactions by Companies or Individuals for Biora Therapeutics, Inc.

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership